Sale!

BBS7 Gene Bardet-Biedl Syndrome Type 7 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The BBS7 Gene Bardet-Biedl Syndrome Type 7 NGS Genetic DNA Test is a comprehensive diagnostic tool that identifies mutations in the BBS7 gene responsible for Bardet-Biedl syndrome type 7. This rare genetic disorder affects multiple organ systems including vision, kidney function, endocrine regulation, and neurological development. Using next-generation sequencing technology, our test provides precise detection of genetic variants that cause this complex syndrome. Early diagnosis through this test enables proactive management of symptoms and complications. The test is priced at $500 USD with a regular price of $700 USD, making advanced genetic testing accessible to patients across the United States. Results are typically available within 3-4 weeks from sample collection.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

BBS7 Gene Bardet-Biedl Syndrome Type 7 NGS Genetic DNA Test

Comprehensive Genetic Analysis for Rare Inherited Disorders

The BBS7 Gene Bardet-Biedl Syndrome Type 7 NGS Genetic DNA Test represents a breakthrough in molecular diagnostics for rare genetic conditions. Bardet-Biedl syndrome is a complex multisystem disorder characterized by retinal degeneration, obesity, polydactyly, renal abnormalities, and learning difficulties. Type 7 specifically involves mutations in the BBS7 gene, which plays a crucial role in ciliary function and cellular signaling pathways.

What This Advanced Genetic Test Measures

Our comprehensive NGS-based test specifically targets the BBS7 gene to identify pathogenic variants that cause Bardet-Biedl syndrome type 7. The test examines:

  • Complete coding regions of the BBS7 gene
  • Exon-intron boundaries for splice site mutations
  • Known pathogenic variants associated with the syndrome
  • Novel mutations that may impact protein function
  • Copy number variations affecting gene dosage

Who Should Consider BBS7 Genetic Testing

This test is recommended for individuals presenting with symptoms suggestive of Bardet-Biedl syndrome, including:

  • Progressive vision loss or retinal dystrophy
  • Early-onset obesity and metabolic abnormalities
  • Renal dysfunction or structural kidney abnormalities
  • Polydactyly (extra fingers or toes)
  • Developmental delays or learning difficulties
  • Endocrine disorders including diabetes and hypogonadism
  • Family history of similar multisystem symptoms

Clinical Benefits of Early Genetic Diagnosis

Obtaining a definitive genetic diagnosis through BBS7 testing provides numerous clinical advantages:

  • Personalized Treatment Planning: Enables targeted management strategies for affected organ systems
  • Family Planning Guidance: Provides recurrence risk information for future pregnancies
  • Proactive Monitoring: Facilitates early intervention for potential complications
  • Accurate Prognosis: Helps predict disease progression and outcomes
  • Eliminates Diagnostic Uncertainty: Confirms clinical suspicions and prevents misdiagnosis

Understanding Your Test Results

Interpretation Guidelines

Our comprehensive genetic report provides detailed interpretation of your BBS7 gene analysis:

  • Positive Result: Indicates the presence of pathogenic variants in the BBS7 gene, confirming Bardet-Biedl syndrome type 7 diagnosis
  • Negative Result: No disease-causing mutations detected in the BBS7 gene, though other genetic causes should be considered
  • Variant of Uncertain Significance: Identifies genetic changes with unclear clinical impact requiring further evaluation
  • Carrier Status: Determines if individuals carry one copy of a mutated gene without showing symptoms

Post-Test Recommendations

Following genetic testing, we recommend:

  • Consultation with a genetic counselor for result interpretation
  • Multidisciplinary care coordination with relevant specialists
  • Regular monitoring of vision, renal function, and metabolic health
  • Family member testing when appropriate
  • Ongoing research participation for rare disease advancement

Test Information and Pricing

Test Parameter Details
Test Name BBS7 Gene Bardet-Biedl Syndrome Type 7 NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology
Specialty Genetics, Hepatology, Nephrology, Endocrinology

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified collection centers ensures accessible genetic testing services nationwide.

Take Control of Your Genetic Health Today

Don’t let uncertainty about genetic conditions affect your health decisions. Our BBS7 Gene Bardet-Biedl Syndrome Type 7 NGS Genetic DNA Test provides the clarity you need for informed medical management. With our discounted price of $500 USD and comprehensive genetic analysis, you can access cutting-edge diagnostic technology without financial burden.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic test consultation and take the first step toward definitive diagnosis and personalized care.

Our experienced genetic counselors are available to discuss your testing options, answer questions about the procedure, and help you understand how genetic testing can benefit your specific health situation. Early diagnosis through advanced genetic testing can significantly improve long-term outcomes for individuals with rare genetic disorders.